3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Carcinoma, Renal Cell
3
Triple Negative Breast Neoplasms
2
Lung Neoplasms
2
Kidney Neoplasms
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Urothelial Bladder Carcinoma
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Recurrence
1
Ovarian Neoplasms
1
Metastatic Urothelial Cancer
1
Melanoma
1
Lung Diseases
1
Glioblastoma
1
Esophageal Neoplasms
1
Erythrocytosis, Familial, 4
1
Cholangiocarcinoma
1
Advanced Solid Tumors
1
Advanced Non-Small Cell Lung Cancer
1
Interventions
Magnetic Resonance Spectroscopy
10
Specimen Handling
9
Cisplatin
7
Radiotherapy, Intensity-Modulated
6
Platinum
6
1,2-diaminocyclohexaneplatinum II citrate
6
pembrolizumab
5
Cetuximab
5
(225)Ac-DOTA-c(RGDyK)
4
Carboplatin
3
Biopsy
3
ipatasertib
2
X-Rays
2
Taxes
2
Radiotherapy
2
Radiation
2
Paclitaxel
2
Interviews as Topic
2
Immunoglobulin G
2
Disulfides
2
peposertib
1
merphos
1
durvalumab
1
dehydroftorafur
1
cabozantinib
1
atezolizumab
1
Tretinoin
1
Surveys and Questionnaires
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hypopharyngeal Neoplasms
×
zimberelimab
×
90 days
×
Clear all
No trials found.